This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better-informed drug policy and action.
Adopted unanimously by the agency’s key...
Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being offered through the...
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid...
Reitox is the European information network on drugs and drug addiction created at the same time as the EMCDDA.
Members of the Reitox network are designated national institutions or agencies responsible for data collection and reporting on...
The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS).
EDWS 1–12...
In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe.
The journey begins with the first report describing the drug situation in 1995 and leads us, over...
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug...
Summary:
This knowledge questionnaire has been developed by the EMCDDA as part of its initiative to increase access to hepatitis C care through drug services. The main aims of the knowledge questionnaire are:
The European Monitoring Centre for Drugs and Drug Addiction have released their first report on the medical use of cannabis.
The report is part of a new series called Cannabis, Controversies and Challenges, and is designed to explore the...
The science of addiction is complicated, and it continues to be a field where the debate over definitions, models, theories, and the most appropriate ways to respond continues.
EMCDDA's Insight Review provides a critical analysis of the...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have released their latest technical report “Monitoring Drug Use in Recreational Settings across Europe: Conceptual Challenges and Methodological Innovations”.
The report...
There were over 9000 fatal overdoses in Europe in 2016. Tackling this concerning issues remains a key priority for public health policy.
The European Monitoring Centre for Drugs and Drugs Addiction has published their latest perspective...
The European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) has released their latest European Drugs report.
Covering 30 European countries the report explores drug trends, developments in prevention and treatment, public health...
The United Kingdom Focal Point on Drugs (UK Focal Point) 2017 report is available on the UK government's digital portal.
Based at Public Health England, the UK Focal Point is the national partner of the European Monitoring Centre for Drugs...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has released the results of their largest wastewater analysis study. The EU project analysed the wastewater around 60 European cities and towns.
This has allowed...
The last decade has seen the emergence of new internet technologies that have acted as important facilitators of online drug markets. The internet now hosts a range of virtual marketplaces (both on the surface and deep web) for...
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) defines contingency management as “a general behavioural intervention technique used in the treatment of drug dependence … designed to weaken drug use and strengthen...
